Recent findings suggest that a personalized approach to recommending CPAP machines to patients with obstructive sleep apnea ...

Moderate to severe OSA was associated with increased risk for severe and critical COVID-19, particularly in those with severe intermittent hypoxia.

Nyxoah (Nasdaq:NYXH) announced today that it received FDA approval for its Genio neuromodulation device for treating sleep apnea.

The first oral pill for obstructive sleep apnea could be around the corner after company Apnimed reported positive results from its stage III clinical trial.

Obstructive sleep apnea is still largely undiagnosed and untreated. In a growing marketplace of solutions, can negative pressure devices compete?

A retrospective study shows sleep apnea can increase the risk for retinal vein occlusion in both men and women and is associated with worse outcomes in patients who already have the condition.

In patients with high-risk obstructive sleep apnea (OSA), continuous positive airway pressure (CPAP) improves cardiovascular outcomes.

Topline results were announced from a second phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in patients with obstructive sleep apnea (OSA).

Join St. Luke’s sleep medicine specialist Joshua Hitchings, MD, as he talks about obstructive sleep apnea, its causes and the compassionate care in addressing it. Dr. Hitchings examines the ...

New research indicates sleep apnea patients who use CPAP machines might face increased risk of heart attack, stroke and other heart-related health conditions.

Tens of millions of people in the United States struggle with obstructive sleep apnea, a condition that occurs when the throat muscles narrow during sleep, leading to temporary pauses in breathing ...